Sherbrooke Park Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
+10,063
| New | +$183K | 0.08% | 405 |
|
|
2025
Q1 | – | Sell |
-20,066
| Closed | -$344K | – | 575 |
|
|
2024
Q4 | $344K | Buy |
20,066
+6,117
| +44% | +$105K | 0.11% | 339 |
|
|
2024
Q3 | $279K | Buy |
13,949
+1,680
| +14% | +$33.6K | 0.06% | 601 |
|
|
2024
Q2 | $137K | Sell |
12,269
-43,035
| -78% | -$481K | 0.02% | 804 |
|
|
2024
Q1 | $365K | Buy |
55,304
+41,357
| +297% | +$273K | 0.07% | 486 |
|
|
2023
Q4 | $63K | Sell |
13,947
-23,997
| -63% | -$108K | 0.03% | 429 |
|
|
2023
Q3 | $136K | Buy |
+37,944
| New | +$136K | 0.04% | 432 |
|